Synergia Lights Up With $10m For Smaller, MRI-Friendly, Rechargeable Neurostim Device
Executive Summary
Belgian Synergia Medical has scored €8.1m ($10.1m) in Series A funding to take the company's vagus nerve stimulation device through to advanced-stage testing before filing for CE marking.